Allergy and Immunology· Topic 1.3 Upper airway and ocular allergy· 1.3.4

Acute invasive fungal rhinosinusitis

Acute invasive fungal rhinosinusitis is an angioinvasive infection of the sinonasal mucosa by Mucorales species or Aspergillus in immunocompromised or diabetic ketoacidosis patients that causes vascular thrombosis and tissue necrosis. It is a surgical and infectious disease emergency requiring same-day biopsy, emergent debridement, and high-dose liposomal amphotericin B, with mortality up to 60-80% even with therapy.

13 min read7 practice questions8 key factsSubscriber article
  • Topic review
    The full article, organized the way the exam asks it.
  • ABIM-format MCQs
    Vignettes with an explanation for every wrong answer.
  • Key facts
    The numbers and thresholds worth memorizing, up front.
  • AI tutor
    MedBrain answers the question you're stuck on.

What this article covers

  • Overview

    Angioinvasive fungal emergency of the sinonasal tract: infection of the nasal and paranasal sinus mucosa by Mucorales (Rhizopus arrhizus, Mucor species) or Aspergillus species that invade vessel…

  • Epidemiology

    Third most common invasive fungal infection in immunocompromised persons: ranks behind candidiasis and aspergillosis in frequency but carries among the highest mortality of the invasive mycoses.

  • Risk factors

    Diabetic ketoacidosis: the classic risk factor; acidosis impairs neutrophil function and favors fungal growth, and rhinocerebral mucormycosis is a recognized life-threatening complication of DKA.

  • Pathophysiology

    Spore inhalation and mucosal inoculation: inhaled spores deposit on nasal and sinus mucosa and germinate in the susceptible host rather than being cleared by neutrophil defenses.

  • Clinical features

    Facial pain, headache, and fever in a high-risk host: the earliest, most common symptoms; their appearance with DKA, neutropenia, or transplantation should trigger urgent evaluation rather than routine sinusitis management.

  • Differential diagnosis

    Bacterial acute rhinosinusitis: purulent discharge and facial pressure without necrotic eschar or orbital signs; responds to antibiotics.

  • Diagnosis

    The diagnosis is confirmed by biopsy showing angioinvasive fungal hyphae on histopathology; there is no formal clinical criteria set or scoring system for this disease.

  • Management

    First, immediately reverse the predisposing condition in parallel with all other steps: correct DKA with insulin and fluids, reduce immunosuppression where feasible, stop deferoxamine, and promote…

  • Complications

    Death: mortality remains as high as 60% to 80% even with aggressive combined surgical and antifungal therapy.

  • Prognosis

    Mortality remains 60% to 80% despite modern combined therapy: driven by speed of diagnosis and surgery, extent of disease at presentation, and reversibility of the underlying immune defect.

  • Prevention

    Aggressive glycemic control to prevent diabetic ketoacidosis: the single most common precipitant of rhinocerebral mucormycosis; any diabetic patient admitted in DKA should have a nasal and oral…

Read the whole article

Subscribing to Internal Medicine opens every article, the full question bank and MedBrain, on the web, iPhone and Android.